We then confirmed the important role of TRIM25 in sustaining CSC properties and inducing resistance of CRC cells to OXA-based treatment both in vitro and in vivo, and revealed a novel molecular mechanism based on the upregulation of EZH2 levels. Here, TRIM25 is linked to colorectal carcinoma.